Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024and expands access to patients and caregivers managing Type 1 Allergic Reactions. SAN D ...
NLS Pharmaceutics ( (NLSP) ) has shared an update.
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...
Supplements are being recalled because they contain prescription diabetes drugs that could have fatal side effects.
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
The main goal of diabetes treatment is to keep your blood sugar levels in target range. To help monitor them, your doctor will order blood work on a regular basis, including an A1C test.
Seeking Alpha on MSN10h
Hims & Hers Health falls as FDA issues unfavorable compounded GLP-1 decisionHims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is no shortage of ...
Ionis won FDA approval for a drug for patients with a deadly genetic disease that impedes the body’s ability to break down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback